ALB and hereditary elliptocytosis: As well, a tool that combines laboratory test results (i.e., low albumin levels, high bilirubin levels) and use of specific medications (i.e., beta-blocker, statin) was developed to help predict outpatients with cirrhosis at risk of HE (118).